Cargando…
ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs)
BACKGROUND: Neuroendocrine neoplasias (NENs) are a rare type of malignancy that arise from the cells of the neuroendocrine system. Most patients present with advanced, unresectable disease, typically with metastases to the liver. The presence of liver metastases dictates prognosis and there has been...
Autores principales: | Sharma, Rohini, Slater, Susanna, Evans, Joanne, Martinez, Maria, Ward, Caroline, Izadi, Hooshang, Wernig, Florian, Thomas, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297626/ https://www.ncbi.nlm.nih.gov/pubmed/35858849 http://dx.doi.org/10.1186/s12885-022-09859-9 |
Ejemplares similares
-
Radioembolization for Hepatocellular Carcinoma using TheraSphere(®)
por: Ali, Safiyya Mohamed
Publicado: (2011) -
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
por: Rognoni, Carla, et al.
Publicado: (2022) -
Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial
por: Chauhan, Nikhil, et al.
Publicado: (2018) -
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial
por: Chauhan, Nikhil, et al.
Publicado: (2019) -
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2020)